Guardant Health
GH
#1093
Rank
โ‚น2.120 T
Marketcap
โ‚น15,992
Share price
-1.63%
Change (1 day)
278.03%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Earnings for Guardant Health (GH)

Earnings in 2026 (TTM): -โ‚น38.92 Billion

According to Guardant Health 's latest financial reports the company's current earnings are โ‚น1.08 Billion. In 2025 the company made an earning of -โ‚น39.75 Billion, an increase over its 2024 earnings that were of -โ‚น41.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Guardant Health from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚น38.92 Billion-2.09%
2025 -โ‚น39.75 Billion-4.03%
2024 -โ‚น41.43 Billion-9.12%
2023 -โ‚น45.58 Billion-26.73%
2022 -โ‚น62.21 Billion69.96%
2021 -โ‚น36.61 Billion56.35%
2020 -โ‚น23.42 Billion252.69%
2019 -โ‚น6.64 Billion-17.22%
2018 -โ‚น8.02 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Neogen
NEOG
-โ‚น59.8 Billion 44.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น27.24 Billion-34.13%๐Ÿ‡บ๐Ÿ‡ธ USA